[三甲基胺N-氧化物通过PI3K/AKT/SREBP1路径诱导纤维化]
Jing Chen1, Yinghui Huang1, Jinghong Zhao1
1( 400037) Department of Nephrology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.
概括
三甲基胺N氧化物 (TMAO) 通过激活PI3K/AKT/SREBP1通路促进纤维化. 这项研究阐明了TMAO在纤维化中的机制,提供了潜在的治疗点.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 毒理学 毒理学 毒理学
- 分子生物学分子生物学
背景情况:
- 三甲基胺N氧化物 (TMAO) 是一种已知的尿素毒素.
- 通过TMAO促进纤维化的具体机制尚未完全理解.
研究的目的:
- 研究TMAO在纤维化中的作用和机制.
- 为了阐明涉及TMAO诱导的损伤的信号通路.
主要方法:
- 小鼠被用TMAO或盐水治疗了8周.
- 脏组织使用组织学和免疫组织化学分析纤维化标志物 (α-SMA,Fibronectin).
- 通过Western blot评估了SREBP1,PI3K和AKT通路组件的蛋白质水平.
- 细胞实验使用siRNA用于SREBP1和PI3K/AKT抑制剂 (LY294002) 来检查途径调节.
主要成果:
- 在小鼠中,TMAO治疗导致显著的损伤和纤维化.
- 在接受TMAO治疗的小鼠中观察到纤维化标志物 (α-SMA,Fibronectin) 和SREBP1的表达增加.
- TMAO上调了PI3K和AKT的酸化,表明该通路的激活.
- 在细胞实验中,SREBP1倒置或PI3K/AKT抑制逆转了TMAO诱导的纤维化标志物表达.
结论:
- TMAO可以诱导纤维化.
- PI3K/AKT/SREBP1信号通路是TMAO诱导纤维化的一个关键机制.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


